Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pete A Williams

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Neural Regeneration Research|January 17, 2025
Targeting Wallerian degeneration in glaucomaMelissa Jöe, Pete A Williams
Drug Design, Development and Therapy|June 23, 2026
Prospects for Neuroprotective Therapies in Glaucoma: Drug Targets and Emerging Clinical StrategiesSeungsoo Rho, Pete A Williams
The American Journal of Pathology|May 29, 2026
Histopathological findings and knowledge gaps in glaucomatous neurodegenerationFlora Hui, Pete A Williams
European Journal of Ophthalmology|February 4, 2026
Vitamins and nutraceuticals in glaucoma researchFlora Hui, Pete A Williams
Neural Regeneration Research|May 20, 2024
Pyrroloquinoline quinone: a potential neuroprotective compound for neurodegenerative diseases targeting metabolismAlessio Canovai, Pete A Williams
Experimental Neurology|June 24, 2026
Programmed axon degeneration gene variants in human diseaseEleanor L Hopkins, Pete A Williams
Neural Regeneration Research|December 16, 2023
Glycolysis and glucose metabolism as a target for bioenergetic and neuronal protection in glaucomaPete A Williams, Robert J Casson
Neural Regeneration Research|December 30, 2025
Treating dysfunctional one-carbon metabolism in glaucomaJames R Tribble, Pete A Williams
Discover Oncology|October 31, 2022
The prognostic implication of latitude in uveal melanoma: a nationwide observational cohort study of all patients born in Sweden between 1947 and 1989Gustav Stålhammar, Pete A Williams, Tomas Landelius
Brain : a Journal of Neurology|September 7, 2010
Opa1 deficiency in a mouse model of dominant optic atrophy leads to retinal ganglion cell dendropathyPete A Williams, James E Morgan, Marcela Votruba
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Neural Regeneration Research|January 17, 2025
Targeting Wallerian degeneration in glaucomaMelissa Jöe, Pete A Williams
Drug Design, Development and Therapy|June 23, 2026
Prospects for Neuroprotective Therapies in Glaucoma: Drug Targets and Emerging Clinical StrategiesSeungsoo Rho, Pete A Williams
The American Journal of Pathology|May 29, 2026
Histopathological findings and knowledge gaps in glaucomatous neurodegenerationFlora Hui, Pete A Williams
European Journal of Ophthalmology|February 4, 2026
Vitamins and nutraceuticals in glaucoma researchFlora Hui, Pete A Williams
Neural Regeneration Research|May 20, 2024
Pyrroloquinoline quinone: a potential neuroprotective compound for neurodegenerative diseases targeting metabolismAlessio Canovai, Pete A Williams
Experimental Neurology|June 24, 2026
Programmed axon degeneration gene variants in human diseaseEleanor L Hopkins, Pete A Williams
Neural Regeneration Research|December 16, 2023
Glycolysis and glucose metabolism as a target for bioenergetic and neuronal protection in glaucomaPete A Williams, Robert J Casson
Neural Regeneration Research|December 30, 2025
Treating dysfunctional one-carbon metabolism in glaucomaJames R Tribble, Pete A Williams
Discover Oncology|October 31, 2022
The prognostic implication of latitude in uveal melanoma: a nationwide observational cohort study of all patients born in Sweden between 1947 and 1989Gustav Stålhammar, Pete A Williams, Tomas Landelius
Brain : a Journal of Neurology|September 7, 2010
Opa1 deficiency in a mouse model of dominant optic atrophy leads to retinal ganglion cell dendropathyPete A Williams, James E Morgan, Marcela Votruba
Pageof 9